metricas
covid
Buscar en
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Toda la web
Inicio Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) Characterization of Elastofibroma Dorsi with 18FDG PET/CT: a retrospective study
Journal Information
Vol. 30. Issue 6.
Pages 342-345 (November 2011)
Share
Share
Download PDF
More article options
Vol. 30. Issue 6.
Pages 342-345 (November 2011)
Characterization of Elastofibroma Dorsi with 18FDG PET/CT: a retrospective study
Caracterización del elastofibroma dorsi con 18FDG-PET/TAC: un estudio retrospectivo
Visits
669
Y.. Blumenkrantza,
Corresponding author
yamiblumen@yahoo.com

Corresponding author. yamiblumen@yahoo.com
, G.L.. Brunoa, C.J.. Gonzáleza, M.. Namíasa, A.R.. Osorioa, P.. Parmaa
a Fundación Centro de Diagnóstico Nuclear, Buenos Aires, Argentina
This item has received
Article information

Elastofibroma dorsi has been described in the literature as an unusual tumor or pseudotumor. However, autopsies and imaging studies have revealed that it is a non-negligible finding.

Purpose

The aim of this study has been to illustrate and become familiar with this type of lesion in order to prevent misdiagnosis.

Materials and methods

From 3 December 2008 to 5 January 2010, 1,751 patients were evaluated with 18FDG-PET/CT. Of these, 29 cases of elastofibroma dorsi were recorded as an incidental finding. A retrospective and descriptive analysis was performed on this study series.

Results

The study showed a prevalence of 1.66%. Out of the 29 findings, 22 (75.86%) were females and 7 (24.14%) males. Seventeen (58.62%) cases were bilateral, 12 (41.38%) unilateral and the SUVmax ranged from 1.4 to 3.2. These lesions were reported as soft tissue density images with mild or moderate diffuse metabolic activity.

Conclusion

The elastofibroma dorsi is a relatively common finding in PET/CT that should be known in order to avoid making wrong diagnoses.

Keywords:
Elastofibroma dorsi
PET/CT
18F-deoxyglucose (FDG)
SUVmax

El elastofibroma dorsi ha sido descrito en la literatura como un tumor o pseudotumor poco frecuente. Sin embargo, autopsias y estudios de imagen han revelado que se trata de un hallazgo no despreciable.

Objetivo

El propósito de este estudio es describir y familiarizarse con este tipo de lesión para así evitar diagnósticos equívocos.

Material y métodos

Del 3 de diciembre de 2008 al 5 de enero de 2010, se evaluaron 1.751 pacientes mediante 18FDG-PET/TAC, de los cuales 29 casos de elastofibroma dorsi fueron reportados como hallazgo incidental.

Resultados

Este estudio mostró una prevalencia del 1,66%. De los 29 casos, 22 (75,86%) fueron mujeres y 7 (24,14%) hombres. Diecisiete (58,62%) casos resultaron bilaterales, 12 (41,38%) unilaterales y el SUVmáx osciló entre 1,4 y 3,2. Dichas lesiones fueron descritas como imágenes con densidad de partes blandas con leve o moderada actividad metabólica difusa.

Conclusión

El elastofibroma dorsi es un hallazgo relativamente frecuente en PET/TAC. Sus características deberían ser conocidas a fin de evitar diagnósticos erróneos.

Palabras clave:
Elastofibroma dorsi
PET-TAC
18F-deoxiglucosa (FDG)
SUVmáx

Article

These are the options to access the full texts of the publication Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos